Cargando…

Scientific statement of the Chinese Society of Cardiology (CSC) on using of renin angiotensin system blockers in patients with cardiovascular disease and COVID-19

Detalles Bibliográficos
Autores principales:	Han, Ya-Ling, Li, Yu-Ming, Ma, Chang-Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Science Press 2020
Materias:	Na
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276313/ https://www.ncbi.nlm.nih.gov/pubmed/32547605 http://dx.doi.org/10.11909/j.issn.1671-5411.2020.05.001

Ejemplares similares

Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers
por: Danser, A.H. Jan, et al.
Publicado: (2020)

Effect of renin angiotensin blockers on angiotensin converting enzyme 2 level in cardiovascular patients
por: Farid fahmy, Sarah, et al.
Publicado: (2023)

Renin-angiotensin system blockers and COVID-19
por: Vidal-Petiot, Emmanuelle, et al.
Publicado: (2021)

NA62 electronics barracks access 2017
por: Graham, Connor
Publicado: (2017)

TELDES top view
por: Bloch-Devaux, Brigitte
Publicado: (2015)

NA62 RICH
por: Pinzino, Jacopo
Publicado: (2016)

NA62 Level 0 trigger: TELDES, TX mezzanine, RX mezzanine integration scenario
por: Lupi, Matteo
Publicado: (2015)

64 STRAW Prototype
por: Danielsson, H
Publicado: (2010)

GigaTracker
por: Fiorini, M, et al.
Publicado: (2010)

LAV 1 Installation
por: Antonelli, A
Publicado: (2008)

NA62 Detector Schematics
por: Valente, P, et al.
Publicado: (2010)

LAV Fabrication and Installation
por: Moulson, M, et al.
Publicado: (2011)

HAC dismantling
por: Hahn, F
Publicado: (2010)

Transport of NA48 Drift Chambers to Dubna
por: GOLOVATYUK, V
Publicado: (2010)

CEDAR+KTAG
por: Goudzovski, Evgueni
Publicado: (2013)

NA62 cavern and sub-detectors 2017
por: Graham, Connor, et al.
Publicado: (2017)

Cardiovascular disease in women: Executive summary of the expert panel statement of women in cardiology of the hellenic cardiological society
por: Chrysohoou, Christina, et al.
Publicado: (2020)

Chinese society of cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis
por: Wang, Daowen, et al.
Publicado: (2018)

Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
por: Mancia, Giuseppe, et al.
Publicado: (2020)

Renin-Angiotensin System Inhibition in Cardiovascular Patients at the Time of COVID19: Much Ado for Nothing? A Statement of Activity from the Directors of the Board and the Scientific Directors of the Italian Society of Hypertension
por: Iaccarino, Guido, et al.
Publicado: (2020)

Lipoprotein(a) and Cardiovascular Disease in Chinese Population: A Beijing Heart Society Expert Scientific Statement
por: Li, Jian-Jun, et al.
Publicado: (2022)

Fixed-Dose Combinations of Renin–Angiotensin System Inhibitors and Calcium Channel Blockers in the Treatment of Hypertension: A Comparison of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors
por: Hsiao, Fu-Chih, et al.
Publicado: (2015)

eCardiology: a structured approach to foster the digital transformation of cardiovascular medicine: Position statement of the German Society of Cardiology
por: Meder, Benjamin, et al.
Publicado: (2023)

Vascular Ultrasound Statement from the Department of Cardiovascular Imaging of the Brazilian Society of Cardiology - 2019
por: dos Santos, Simone Nascimento, et al.
Publicado: (2019)

Association of Renin-Angiotensin System Blockers With Outcomes in Patients with COVID-19
por: Garg, Aakash, et al.
Publicado: (2020)

Association of Renin-Angiotensin System Blockers with Survival in Patients on Maintenance Hemodialysis
por: Kang, Seok Hui, et al.
Publicado: (2023)

Renin-Angiotensin System and Cardiovascular Functions
por: Wu, Chia-Hua, et al.
Publicado: (2018)

Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement
por: Wong, Nathan D., et al.
Publicado: (2022)

A current evaluation of the safety of angiotensin receptor blockers and direct renin inhibitors
por: Siragy, Helmy M
Publicado: (2011)

Dapagliflozin reduces albuminuria in patients with diabetes and hypertension receiving renin‐angiotensin blockers
por: Heerspink, H. J. L., et al.
Publicado: (2016)

Renin-angiotensin system blockers regulate the metabolism of isolated fat cells in vitro
por: Caminhotto, R de O., et al.
Publicado: (2016)

Renin-angiotensin system blockers and severe acute respiratory syndrome coronavirus 2
por: Lévy, Bernard I., et al.
Publicado: (2020)

In reply— Association of Renin-Angiotensin System Blockers with Outcomes in Patients With COVID-19
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Impact of renin-angiotensin system inhibitors and beta-blockers on dental implant stability
por: Saravi, Babak, et al.
Publicado: (2021)

Impact of Renin‐Angiotensin System Blockers on Mortality in Veterans Undergoing Cardiac Surgery
por: Antoniak, Derrick T., et al.
Publicado: (2021)

Effect of renin-angiotensin system blocker on COVID-19 in young patients with hypertension
por: Kuzeytemiz, Mustafa, et al.
Publicado: (2022)

Genetic Variant of the Renin-Angiotensin System and Diabetes Influences Blood Pressure Response to Angiotensin Receptor Blockers
por: Konoshita, Tadashi, et al.
Publicado: (2009)

Position Statement of the Brazilian Cardiology Society and the Brazilian Society of Hemodynamics and Interventional Cardiology on Training Centers and Professional Certification in Hemodynamics and Interventional Cardiology - 2020
por: de Arruda, José Airton, et al.
Publicado: (2020)

Defining preventive cardiology: A clinical practice statement from the American Society for Preventive Cardiology
por: German, Charles A., et al.
Publicado: (2022)

Angiotensin II Receptor Blocker Attenuates Intrarenal Renin-Angiotensin-System and Podocyte Injury in Rats with Myocardial Infarction
por: Wen, Zhu-zhi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_uap59ig8lksaipdh2ema21i488